CYBIN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.830 USD | -0.79% |
|
-11.96% | +0.11% |
| Dec. 11 | Cybin Inc. - Special Call | |
| Nov. 18 | Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year | MT |
Sales 2024 by Business Segment
See more
© MarketScreener.com
Sales 2024 by Geography
See more
© MarketScreener.com
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Breakdown by Business Segment (CAD)
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Pharmaceutical Products | |||||
Total Assets | - | - | 84.06M | 53.9M | 302M |
CAPEX | - | - | -520K | -3.31M | -21K |
EBT | - | - | -67.63M | -47.49M | -78.08M |
D&A | - | - | 168K | 233K | 400K |
Net Income | - | - | -67.63M | -47.49M | -78.08M |
Geographical Revenue Distribution History
Geographical breakdown of sales (CAD)
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
- Stock Market
- Equities
- CLXPF Stock
- Financials Cybin Inc.
- Business Segments